Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BBNX Beta Bionics, Inc.

盘后交易 02-06 16:51:33 EST

13.08

-0.16

-1.21%

盘后13.08

+0.000.00%

16:17 EST

最高13.66	最低12.90	成交量129.32万
今开13.47	昨收13.24	日振幅5.74%
总市值5.76亿	流通市值3.10亿	总股本4,402万
成交额1,695万	换手率5.46%	流通股本2,370万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":13.08,"timestamp":1770411600000,"preClose":13.24,"halted":0,"volume":1293167,"hourTrading":{"tag":"盘后","latestPrice":13.08,"preClose":13.08,"latestTime":"16:17 EST","volume":6195,"amount":81030.6,"timestamp":1770412639340,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.012084592145015116,"floatShares":23702000,"shares":44024631,"eps":-1.769,"marketStatus":"盘后交易","change":-0.16,"latestTime":"02-06 16:51:33 EST","open":13.47,"high":13.66,"low":12.9,"amount":16947772.109711,"amplitude":0.057402,"askPrice":14,"askSize":10,"bidPrice":12.9,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-1.769,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770426000000},"marketStatusCode":4,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":13.24,"preHourTrading":{"tag":"盘前","latestPrice":13.05,"preClose":13.24,"latestTime":"09:03 EST","volume":5,"amount":65.25,"timestamp":1770386591341,"change":-0.19,"changeRate":-0.01435,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":13.08,"preClose":13.08,"latestTime":"16:17 EST","volume":6195,"amount":81030.6,"timestamp":1770412639340,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.065695,"impliedVol":0.9675,"impliedVolPercentile":0.7966},"requestUrl":"/m/hq/s/BBNX","defaultTab":"news","newsList":[{"id":"2605480793","title":"Beta Bionics, Inc.盘中异动 快速下挫5.05%报17.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605480793","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605480793?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:59","pubTimestamp":1769007564,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日22时59分，Beta Bionics, Inc.股票出现波动，股价急速跳水5.05%。Beta Bionics, Inc.股票所在的医疗器械行业中，整体涨幅为0.54%。Beta Bionics, Inc.公司简介：Beta Bionics Inc 是一家商业化阶段的医疗器械公司，致力于设计、开发和商业化解决方案，通过利用自适应闭环算法简化和改善其疾病治疗，改善需要胰岛素的糖尿病患者  的健康和生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012122592497a2cf1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012122592497a2cf1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2603641539","title":"Beta Bionics, Inc.盘中异动 临近午盘股价大跌5.10%报16.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603641539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603641539?lang=zh_cn&edition=full","pubTime":"2026-01-15 00:46","pubTimestamp":1768409202,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日00时46分，Beta Bionics, Inc.股票出现波动，股价快速下跌5.10%。截至发稿，该股报16.39美元/股，成交量51.9876万股，换手率1.18%，振幅4.92%。Beta Bionics, Inc.股票所在的医疗器械行业中，整体跌幅为0.17%。Beta Bionics, Inc.公司简介：Beta Bionics Inc 是一家商业化阶段的医疗器械公司，致力于设计、开发和商业化解决方案，通过利用自适应闭环算法简化和改善其疾病治疗，改善需要胰岛素的糖尿病患者  的健康和生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011500464297a1d55d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011500464297a1d55d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2583183505","title":"Beta Bionics, Inc.盘中异动 下午盘急速下跌5.01%报26.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583183505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583183505?lang=zh_cn&edition=full","pubTime":"2025-11-14 02:17","pubTimestamp":1763057853,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日02时17分，Beta Bionics, Inc.股票出现波动，股价急速跳水5.01%。截至发稿，该股报26.75美元/股，成交量18.1097万股，换手率0.41%，振幅8.43%。Beta Bionics, Inc.股票所在的医疗器械行业中，整体涨幅为0.56%。Beta Bionics, Inc.公司简介：Beta Bionics Inc 是一家商业化阶段的医疗器械公司，致力于设计、开发和商业化解决方案，通过利用自适应闭环算法简化和改善其疾病治疗，改善需要胰岛素的糖尿病患者  的健康和生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114021733a6f798eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114021733a6f798eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"1115917472","title":"异动解读 | 贝塔生物电子股价盘中大涨19.07%，分析师上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1115917472","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115917472?lang=zh_cn&edition=full","pubTime":"2025-10-29 22:41","pubTimestamp":1761748867,"startTime":"0","endTime":"0","summary":"周三盘中，贝塔生物电子（Beta Bionics，股票代码：BBNX）股价大涨19.07%，引起投资者广泛关注。\n\n消息面上，华尔街知名投资银行Leerink Partners对贝塔生物电子的前景看好，将该公司的目标股价从28美元上调至33美元。这一利好消息被认为是推动公司股价大幅上涨的主要原因。\n\n分析人士认为，Leerink Partners上调目标价反映了对贝塔生物电子未来发展的积极预期。这可能与公司在人工智能辅助糖尿病管理系统方面的创新和市场潜力有关。然而，投资者仍需密切关注公司未来的财务表现和产品开发进展，以评估这一股价上涨是否具有持续性。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BBNX"],"gpt_icon":0},{"id":"1153684762","title":"异动解读 | 贝塔生物电子股价盘前大涨14.87%，Leerink Partners上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1153684762","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153684762?lang=zh_cn&edition=full","pubTime":"2025-10-29 16:18","pubTimestamp":1761725922,"startTime":"0","endTime":"0","summary":"周三盘前，贝塔生物电子（Beta Bionics，股票代码：BBNX）股价大涨14.87%，引起投资者广泛关注。\n\n消息面上，华尔街知名投资银行Leerink Partners对贝塔生物电子的前景看好，将该公司的目标股价从28美元上调至33美元。这一利好消息可能是推动公司股价大幅上涨的主要原因。\n\n分析人士认为，Leerink Partners上调目标价反映了对贝塔生物电子未来发展的积极预期。这可能与公司在人工智能辅助糖尿病管理系统方面的创新和市场潜力有关。然而，投资者仍需密切关注公司未来的财务表现和产品开发进展，以评估这一股价上涨是否具有持续性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BBNX"],"gpt_icon":0},{"id":"2578269479","title":"Beta Bionics旗下输注器械类产品获FDA批准，注册证号为K252770","url":"https://stock-news.laohu8.com/highlight/detail?id=2578269479","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578269479?lang=zh_cn&edition=full","pubTime":"2025-10-27 10:01","pubTimestamp":1761530460,"startTime":"0","endTime":"0","summary":"产品名称：iLet ACE Pump，所属单位：Beta Bionics，产品类型：输注器械，产品详情：iLet ACE Pump是一款具备备用控制器功能的胰岛素泵，适用于 6 岁及以上糖尿病患者。iLet ACE Pump配备图形用户界面和警报功能，可实现与 iLet 输注系统及 iAGC 的交互操作。iLet ACE Pump搭载电机传动式输注机构，可独立驱动胰岛素从 “单独装入泵体的药筒” 中输出。审批机构：FDA，证件类型：二类，注册证编号：K252770，获批时间：2025-09-29","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510271008369743cf1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510271008369743cf1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2513777845","title":"Beta Bionics(BBNX.US)获Stifel首次覆盖，给予买入评级, 目标价25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513777845","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513777845?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:21","pubTimestamp":1740410466,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Stifel首次覆盖，给予买入评级, 目标价25.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24232148353170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2513722329","title":"Beta Bionics(BBNX.US)获Lake Street首次覆盖，给予买入评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722329?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:22","pubTimestamp":1740406925,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Lake Street首次覆盖，给予买入评级, 目标价30.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24222248352806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2513272995","title":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖，给予增持评级, 目标价26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272995","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513272995?lang=zh_cn&edition=full","pubTime":"2025-02-24 21:21","pubTimestamp":1740403316,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Piper Sandler首次覆盖，给予增持评级, 目标价26.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24212148352460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0},{"id":"2513723151","title":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖，给予优于大市评级, 目标价28.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723151","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513723151?lang=zh_cn&edition=full","pubTime":"2025-02-24 20:20","pubTimestamp":1740399654,"startTime":"0","endTime":"0","summary":"Beta Bionics(BBNX.US)获Leerink Partners首次覆盖，给予优于大市评级, 目标价28.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24202048351403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BBNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.betabionics.com","stockEarnings":[{"period":"1week","weight":-0.1048},{"period":"1month","weight":-0.5783},{"period":"3month","weight":-0.4966},{"period":"6month","weight":-0.1018},{"period":"1year","weight":-0.4203},{"period":"ytd","weight":-0.5655}],"compareEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1215},{"period":"ytd","weight":-0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beta Bionics, Inc.于2015年10月21日作为马萨诸塞州福利公司注册成立，并于2024年8月转换为特拉华州公司。公司是一家商业化阶段的医疗器械公司，从事创新解决方案的设计、开发和商业化，通过利用先进的自适应闭环算法简化和改善其疾病的治疗，提高胰岛素需求糖尿病患者的健康和生活质量。","exchange":"NASDAQ","name":"Beta Bionics, Inc.","nameEN":"Beta Bionics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beta Bionics, Inc.,BBNX,Beta Bionics, Inc.股票,Beta Bionics, Inc.股票老虎,Beta Bionics, Inc.股票老虎国际,Beta Bionics, Inc.行情,Beta Bionics, Inc.股票行情,Beta Bionics, Inc.股价,Beta Bionics, Inc.股市,Beta Bionics, Inc.股票价格,Beta Bionics, Inc.股票交易,Beta Bionics, Inc.股票购买,Beta Bionics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beta Bionics, Inc.(BBNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beta Bionics, Inc.(BBNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}